More articles from Drug Discovery and Translational Medicine

Open Access
Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease
Ughetta del Balzo, Pierre E. Signore, Gail Walkinshaw, Todd W. Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael P. Arend, Lee A. Flippin, F. Aisha Chow, David C. Gervasi, Christian H. Kjaergaard, Ingrid Langsetmo, Volkmar Guenzler, David Y. Liu, Steve J. Klaus, Al Lin and Thomas B. Neff

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 342-353; DOI: https://doi.org/10.1124/jpet.120.265181
You have access
Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures
Etienne Guillot, Jean-Christophe Le Bail, Pascal Paul, Valérie Fourgous, Pascale Briand, Michel Partiseti, Bruno Cornet, Philip Janiak and Christophe Philippo

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 283-294; DOI: https://doi.org/10.1124/jpet.120.265454
Open Access
Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy
Niu Shin, Matthew Stubbs, Holly Koblish, Eddy W. Yue, Maxim Soloviev, Brent Douty, Kathy He Wang, Qian Wang, Mingming Gao, Patricia Feldman, Gengjie Yang, Leslie Hall, Michael Hansbury, Sybil O’Connor, Lynn Leffet, Robert Collins, Kamna Katiyar, Xin He, Paul Waeltz, Paul Collier, Jin Lu, Yun-Long Li, Yanlong Li, Phillip C.C. Liu, Timothy Burn, Maryanne Covington, Sharon Diamond, Dana Shuey, Alan Roberts, Swamy Yeleswaram, Greg Hollis, Brian Metcalf, Wenqing Yao, Reid Huber, Andrew Combs, Robert Newton and Peggy Scherle

Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 211-222; DOI: https://doi.org/10.1124/jpet.120.265538
Open Access
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease
Susanna Waters, Clas Sonesson, Peder Svensson, Joakim Tedroff, Manolo Carta, Elisabeth Ljung, Jenny Gunnergren, Malin Edling, Boel Svanberg, Anne Fagerberg, Johan Kullingsjö, Stephan Hjorth and Nicholas Waters

Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 113-125; DOI: https://doi.org/10.1124/jpet.119.264226
Open Access
Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related Peptide
Leon F. Garcia-Martinez, Carol J. Raport, Ethan W. Ojala, Benjamin Dutzar, Katie Anderson, Erica Stewart, Brian Kovacevich, Brian Baker, Jens Billgren, Michelle Scalley-Kim, Charlie Karasek, Dan Allison and John A. Latham

Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 93-103; DOI: https://doi.org/10.1124/jpet.119.264671
You have access
TAS-303 Ameliorates Carbachol-Induced Detrusor Overactivity in Rats, Revealing Its Therapeutic Potential for Overactive Bladder
Hiroya Mizutani, Fukumitsu Sakakibara and Eiji Sasaki

Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 84-92; DOI: https://doi.org/10.1124/jpet.119.264572
You have access
Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice
Corinne G. Jolivalt, Katie E. Frizzi, May Madi Han, Andre J. Mota, Lucie S. Guernsey, Lakshmi P. Kotra, Paul Fernyhough and Nigel A. Calcutt

Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 44-51; DOI: https://doi.org/10.1124/jpet.120.265447
You have access
The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy
Anna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen

Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 74-83; DOI: https://doi.org/10.1124/jpet.119.263392
Open Access
Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities
Marie-Laure Ozoux, Véronique Briand, Michel Pelat, Fabrice Barbe, Paul Schaeffer, Philippe Beauverger, Bruno Poirier, Jean-Michel Guillon, Frédéric Petit, Jean-Michel Altenburger, Jean-Pierre Bidouard and Philip Janiak

Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 24-37; DOI: https://doi.org/10.1124/jpet.120.265496
You have access
The Development and Characterization of an scFv-Fc Fusion–Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse
Charles E. Hay, Laura E. Ewing, Michael D. Hambuchen, Shannon M. Zintner, Juliana C. Small, Chris T. Bolden, William E. Fantegrossi, Paris Margaritis, S. Michael Owens and Eric C. Peterson

Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 16-23; DOI: https://doi.org/10.1124/jpet.119.261180

Main menu

User menu

Search

More articles from Drug Discovery and Translational Medicine

Pages

Navigate

More Information

ASPET's Other Journals